An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody in Acquired Hemophilia A
Condition: Acquired Hemophilia Intervention: Drug: Daratumumab Sponsor: Institute of Hematology & Blood Diseases Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2023 Category: Research Source Type: clinical trials